搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 小时
Weight Loss Diet Plans for Men: 6 Steps for Going Back to Basics
If you’ve thought about losing weight lately, you’re not alone. And you’re far from the first guy to look up the best weight ...
2 小时
on MSN
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients on obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's ...
2 小时
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
verywellhealth
3 小时
Why Is Losing Weight So Hard? 7 Factors That Play a Role
Losing weight can be difficult for many reasons, including your genetics, hormones, metabolism, lifestyle factors, and mental ...
devdiscourse
5 小时
Zepbound Triumphs Over Wegovy in Obesity Drug Race
In a landmark trial, Eli Lilly's obesity drug Zepbound surpassed Novo Nordisk's Wegovy, showing 47% more weight loss. The ...
The Financial Express
5 小时
Lilly’s Zepbound outshines Wegovy in weight loss head-to-head trial
Wegovy was approved in the US as a treatment for heart disease in March, while Zepbound is expected to be given the green ...
7 小时
Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
A rival drug company is celebrating results claiming its drug helps patients lose more weight than Novo Nordisk’s Wegovy. Eli ...
Bonner County Daily Bee
9 小时
Even with obesity drugs, some don't lose weight
Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust ...
News Medical
11 小时
Disrupted sleep-wake rhythms linked to liver disease progression
The prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈